Obatoclax
http://dbpedia.org/resource/Obatoclax an entity of type: Thing
Obatoclax mesylate, also known as GX15-070, is an experimental drug for the treatment of various types of cancer. It was discovered by Gemin X, which was acquired by Cephalon, which has since been acquired by Teva Pharmaceuticals. Several Phase II clinical trials were completed that investigated use of Obatoclax in the treatment of leukemia, lymphoma, myelofibrosis, and mastocytosis.
rdf:langString
Обатоклакс — экспериментальный препарат для лечения различных видов злокачественных опухолей. Он был открыт фирмой Gemin X, которая затем была приобретена фирмой Cephalon. В настоящее время Обатоклакс находится в II фазе клинических испытаний для лечения лейкозов, лимфомы, миелофиброза и мастоцитоза.
rdf:langString
rdf:langString
Obatoclax
rdf:langString
Обатоклакс
xsd:integer
31273464
xsd:integer
1043804517
rdf:langString
Obatoclax.svg
xsd:integer
200
xsd:integer
2
rdf:langString
GX15-070
rdf:langString
Obatoclax mesylate, also known as GX15-070, is an experimental drug for the treatment of various types of cancer. It was discovered by Gemin X, which was acquired by Cephalon, which has since been acquired by Teva Pharmaceuticals. Several Phase II clinical trials were completed that investigated use of Obatoclax in the treatment of leukemia, lymphoma, myelofibrosis, and mastocytosis.
rdf:langString
Обатоклакс — экспериментальный препарат для лечения различных видов злокачественных опухолей. Он был открыт фирмой Gemin X, которая затем была приобретена фирмой Cephalon. В настоящее время Обатоклакс находится в II фазе клинических испытаний для лечения лейкозов, лимфомы, миелофиброза и мастоцитоза.
xsd:nonNegativeInteger
7247
rdf:langString
GX15-070
rdf:langString
2-(2-((3,5-Dimethyl-1H-pyrrol-2-yl)methylene)-3-methoxy-2H-pyrrol-5-yl)-1H-indole